Form 4 for RIGL RIGEL PHARMACEUTICALS INC
Accepted 2026-06-03 18:02:24 ET · period of report 2026-06-01 · accession 0000905148-26-002809 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-03 18:02 | 2026-06-01 | RIGL | Rojkjaer Lisa | EVP, Chief Medical Off | F - Tax | $29.86 | -850 | 34.0K | -2% | -$25.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-06-01 | F | D | 850 | $29.86 | 34,003 | D | — | — |